Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The effects of 5-lipoxygenase inhibitors and leukotriene antagonists on the development of gastric lesions induced by nonsteroidal antiinflammatory drugs in mice.

× No keyword cloud information.

11 in total

1. Synthesis of [[(naphthalenylmethoxy)- and [[(quinolinylmethoxy)phenyl]amino]oxoalkanoic acid esters. A novel series of leukotriene D4 antagonists and 5-lipoxygenase inhibitors.

Authors: J H Musser; D M Kubrak; J Chang; A J Lewis
Journal: J Med Chem Date: 1986-08 Impact factor: 7.446

Review 2. Autonomic pharmacology of leukotrienes.

Authors: G Feuerstein
Journal: J Auton Pharmacol Date: 1985-06

3. Evidence for differing leukotriene receptors in gastric mucosa.

Authors: R G Pendleton; J R Stavorski
Journal: Eur J Pharmacol Date: 1986-06-17 Impact factor: 4.432

4. Selective inhibition of leukotriene C4 synthesis in human neutrophils by ethacrynic acid.

Authors: K H Leung
Journal: Biochem Biophys Res Commun Date: 1986-05-29 Impact factor: 3.575

5. Gastric ulcerogenicity of non-steroidal anti-inflammatory drugs in mice with mucosa sensitized by cholinomimetic treatment.

Authors: K D Rainsford
Journal: J Pharm Pharmacol Date: 1987-08 Impact factor: 3.765

6. L-649,923, sodium (beta S, gamma R)-4-(3-(4-acetyl-3-hydroxy-2-propylphenoxy)-propylthio)- gamma-hydroxy-beta-methylbenzenebutanoate, a selective, orally active leukotriene receptor antagonist.

Authors: T R Jones; R Young; E Champion; L Charette; D Denis; A W Ford-Hutchinson; R Frenette; J Y Gauthier; Y Guindon; M Kakushima
Journal: Can J Physiol Pharmacol Date: 1986-08 Impact factor: 2.273

7. Comparison of the action of cholinomimetics and pentagastrin on gastric secretion in dogs.

Authors: D F Magee; S Naruse; A Pap
Journal: Br J Pharmacol Date: 1985-02 Impact factor: 8.739

8. Arachidonic acid metabolites and the gastro-intestinal toxicity of anti-inflammatory agents.

Authors: B J Whittle
Journal: Prostaglandins Date: 1981

9. Investigation of the vascular actions of arachidonate lipoxygenase and cyclo-oxygenase products on the isolated perfused stomach of rat and rabbit.

Authors: P Salvati; B J Whittle
Journal: Prostaglandins Date: 1981-07

10. LY171883, 1-less than 2-hydroxy-3-propyl-4-less than 4-(1H-tetrazol-5-yl) butoxy greater than phenyl greater than ethanone, an orally active leukotriene D4 antagonist.

Authors: J H Fleisch; L E Rinkema; K D Haisch; D Swanson-Bean; T Goodson; P P Ho; W S Marshall
Journal: J Pharmacol Exp Ther Date: 1985-04 Impact factor: 4.030

26 in total

Review 1. Non-steroidal anti-inflammatory drug-induced gastropathy. Mechanisms and management.

Authors: S Szabo; W F Spill; K D Rainsford
Journal: Med Toxicol Adverse Drug Exp Date: 1989 Mar-Apr

2. Flavocoxid, a dual inhibitor of cyclooxygenase-2 and 5-lipoxygenase, reduces pancreatic damage in an experimental model of acute pancreatitis.

Authors: F Polito; A Bitto; N Irrera; F Squadrito; C Fazzari; L Minutoli; D Altavilla
Journal: Br J Pharmacol Date: 2010-11 Impact factor: 8.739

The effects of 5-lipoxygenase inhibitors and leukotriene antagonists on the development of gastric lesions induced by nonsteroidal antiinflammatory drugs in mice.

1. Synthesis of [[(naphthalenylmethoxy)- and [[(quinolinylmethoxy)phenyl]amino]oxoalkanoic acid esters. A novel series of leukotriene D4 antagonists and 5-lipoxygenase inhibitors.

Review 2. Autonomic pharmacology of leukotrienes.

3. Evidence for differing leukotriene receptors in gastric mucosa.

4. Selective inhibition of leukotriene C4 synthesis in human neutrophils by ethacrynic acid.

5. Gastric ulcerogenicity of non-steroidal anti-inflammatory drugs in mice with mucosa sensitized by cholinomimetic treatment.

6. L-649,923, sodium (beta S, gamma R)-4-(3-(4-acetyl-3-hydroxy-2-propylphenoxy)-propylthio)- gamma-hydroxy-beta-methylbenzenebutanoate, a selective, orally active leukotriene receptor antagonist.

7. Comparison of the action of cholinomimetics and pentagastrin on gastric secretion in dogs.

8. Arachidonic acid metabolites and the gastro-intestinal toxicity of anti-inflammatory agents.

9. Investigation of the vascular actions of arachidonate lipoxygenase and cyclo-oxygenase products on the isolated perfused stomach of rat and rabbit.

10. LY171883, 1-less than 2-hydroxy-3-propyl-4-less than 4-(1H-tetrazol-5-yl) butoxy greater than phenyl greater than ethanone, an orally active leukotriene D4 antagonist.

Review 1. Non-steroidal anti-inflammatory drug-induced gastropathy. Mechanisms and management.

2. Flavocoxid, a dual inhibitor of cyclooxygenase-2 and 5-lipoxygenase, reduces pancreatic damage in an experimental model of acute pancreatitis.

3. Antiulcerogenic activity of ethanolic leaf extract of Lasianthera africana.

Review 4. The role of prostaglandins in gastric mucosal protection.

Review 5. Cyclo-oxygenase isoenzymes. How recent findings affect thinking about nonsteroidal anti-inflammatory drugs.

6. Proceedings of the British Pharmacological Society. London, 19th-21st December. Abstracts.

7. Determination of the antiulcer properties of sodium cromoglycate in pylorus-ligated albino rats.

8. Eicosanoid and gastroprotection by copper derivatives and NDGA.

9. Leukotrienes in the pathogenesis of NSAID-induced gastric and intestinal mucosal damage.

Review 10. The problems and pitfalls of NSAID therapy in the elderly (Part II).